Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Fluvoxamine maleate

Fluvoxamine maleate

pharmaceutical raw materials
Fluvoxamine maleate structure

Fluvoxamine maleate 

structure
  • CAS No:

    61718-82-9

  • Formula:

    C15H21F3N2O2.C4H4O4

  • Chemical Name:

    Fluvoxamine maleate

  • Synonyms:

    1-Pentanone,5-methoxy-1-[4-(trifluoromethyl)phenyl]-,O-(2-aminoethyl)oxime,(1E)-,(2Z)-2-butenedioate (1:1);1-Pentanone,5-methoxy-1-[4-(trifluoromethyl)phenyl]-,O-(2-aminoethyl)oxime,(E)-,(Z)-2-butenedioate (1:1);Fluvoxamine maleate;Faverin 50;Luvox;DU 23000;Avoxin;Avoksin;Depromel;Fevarin;Dumirox;MK 264;Floxyfral;Maveral;Faverin;NSC 309469;Faverine;54739-20-7

  • Categories:

    Active Pharmaceutical Ingredients  >  Inhibitor Drugs

Description

Fluvoxamine maleate is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.Target: SSRIsFluvoxamine (maleate) is the maleate salt form of fluvoxamine, which is effective in inhibiting 5-HT uptake by blood platelets and brain synaptosomes. The antagonism by fluvoxamine of the reserpine-induced lowering of the pentamethylenetetrazole convulsive threshold can be regarded as due to an effect upon 5-HT uptake. In contrast to the effects of desmethyl


A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.

Fluvoxamine maleate Basic Attributes

434.41

434.166473

228-994-3

DTXSID3042558

2928000090

Characteristics

131 Ų

3.61360

solid

120-121.5 °C

370.6°C at 760 mmHg

9℃

H2O: soluble

2-8°C

Safety Information

UN1230 - class 3 - PG 2 - Methanol, solution

3

22-36/37/38

36-36/37/39-27-26

SA9230000

Xn,Xi

P301 + P312 + P330

H302

|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P273, P280, P301+P312, P304+P312, P304+P340, P305+P351+P338, P310, P312, P330, P391, P403+P233, P405, and P501|Aggregated GHS information provided by 199 companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)|Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)|Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Serotonin Uptake Inhibitors.)|Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inhibitors.)|Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C19. (See all compounds classified as Cytochrome P-450 CYP2C19 Inhibitors.)

Desiflu

Fluvoxamine maleate Use and Manufacturing

Methods of Manufacturing

Preparation of Crude Fluvoxamine Maleate Formula I (0046) To a prepared solution of dimethyl sulphoxide (575 ml), potassium hydroxide flakes (114.64 gm) and water (69 ml), stage-1 (115 gm) was added at temperature 40-45° C. The reaction mixture was stirred to get clear solution followed by adding 2-chloroethylamine hydrochloride (8636 gm) drop wise into the reaction mixture at temperature 40-45° C. and maintained for 1-2 hour. Water (1150 ml) was added in to the reaction mixture at temperature 25-30° C. and stirred for 20-25 minutes. Then toluene (575 ml×2) was added and stirred for 30 minutes and preceded for separation of layers followed by washing the toluene layer with water (1150×5 ml). The solution of maleic acid (48.47 gm) dissolved in water (98 ml) was added into above obtained toluene layer and stirred at temperature 25-30° C. for 2-3 hours. The reaction mixture was cooled to 0-5° C. and maintained for 30-40 minutes at the same temperature. The obtained material was washed with toluene, filtered and such dried. The wet cake was then added hexane (600 ml) and stirred for 30 minutes at temperature 25-30° C., filtered, washed with hexane and dried to get 161 gm of title compound. HPLC purity: >98.5percent

Uses

Anxiety disorder

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:434.4
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:11
Exact Mass:434.16647101
Monoisotopic Mass:434.16647101
Topological Polar Surface Area:131
Heavy Atom Count:30
Complexity:446
Undefined Bond Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Pharmacological action not specified

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • DASAMI LAB PRIVATE LTD

    United States United States
    Active
  • APOTEX PHARMACHEM INDIA PVT LTD

    United States United States
    Active
  • ALIVUS LIFE SCIENCES LTD

    United States United States
    Active

Recommended Suppliers of Fluvoxamine maleate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.